Chronic kidney disease, preoperative use of antispasmodics and lower resected prostate volume ratios are risk factors for postoperative use of adrenergic Alpha-blockers and antispasmodics

This study investigates factors that lead to the need for medications (alpha-blockers and antispasmodics) after prostate surgery for benign prostatic hyperplasia (BPH). It examines patient data to identify characteristics that might predict the need for these medications post-surgery. The study found that patients with chronic kidney disease (CKD) were more likely to require alpha-blockers after surgery. Additionally, those who used antispasmodics before surgery and had a lower ratio of prostate tissue removed during surgery were more prone to needing antispasmodics afterward. These findings can help doctors better understand which patients might need continued medication after prostate surgery and adjust treatment plans accordingly.

• 1
  Chronic kidney disease (CKD) is associated with increased postoperative usage of adrenergic alpha-blockers.
• 2
  Preoperative usage of antispasmodics is a risk factor for postoperative antispasmodic usage.
• 3
  A lower resected prostate volume ratio is a protective factor against postoperative antispasmodic medications.